CLINICAL_TRIALS
withdrawal
· 2026-03-12
Clinical Trial Update: Lifestyle MIND- Feasibility of Wait-list Control [NA]
Summary
A feasibility trial of a Lifestyle MIND intervention for individuals with Type 2 diabetes mellitus and serious mental illness (including schizophrenia, major de…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes Mellitus, Serious Mental Illness | NA | Status: WITHDRAWN